SG Americas Securities’s 89bio ETNB Stock Holding History

SG Americas Securities’s Portfolio ETNB Stock Details ETNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-49,731	Closed	-$731K	–	3651
2025 Q3	$731K	Buy	+49,731	New	+$507K	﹤0.01%	1769
2025 Q2	–	Sell	-24,865	Closed	-$181K	–	3133
2025 Q1	$181K	Sell	24,865 -11,460	-32%	-$100K	﹤0.01%	2601
2024 Q4	$284K	Buy	36,325 +5,612	+18%	+$46.2K	﹤0.01%	1842
2024 Q3	$227K	Buy	30,713 +5,421	+21%	+$45.6K	﹤0.01%	2394
2024 Q2	$203K	Buy	+25,292	New	+$226K	﹤0.01%	2163
2024 Q1	–	Sell	-28,319	Closed	-$316K	–	3102
2023 Q4	$316K	Buy	+28,319	New	+$260K	﹤0.01%	1795
2023 Q2	–	Sell	-10,803	Closed	-$165K	–	2539
2023 Q1	$165K	Buy	10,803 +184	+2%	+$2.4K	﹤0.01%	2563
2022 Q4	$135K	Buy	+10,619	New	+$95.5K	﹤0.01%	2508
2021 Q4	–	Sell	-5,661	Closed	-$111K	–	3508
2021 Q3	$111K	Buy	+5,661	New	+$103K	﹤0.01%	3613

Other funds holding ETNB

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

SG Americas Securities's ETNB Position: Q4 2025 in Review

SG Americas Securities sold out of 89bio (ETNB) in Q4 2025, closing a stake of 49,731 shares — an estimated $731K sold.

SG Americas Securities first reported a position in ETNB in Q3 2021 and held it in 9 quarters. The position peaked at $731K in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

SG Americas Securities reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
SG Americas Securities sold 49,731 89bio shares in Q4 2025, an estimated $731K.
SG Americas Securities first reported a position in 89bio in Q3 2021 and held it in 9 quarters.
SG Americas Securities's 89bio position peaked at $731K in Q3 2025.
2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on SG Americas Securities's 13F filing for Q4 2025, filed 9 Jan 2026.